Evidence map›Paper›PMID 40156912›Full record

ArticleThe international journal of neuropsychopharmacology2025

Premorbid characteristics of the SAPAP3 mouse model of obsessive-compulsive disorder: behavior, neuroplasticity, and psilocybin treatment.

Michal Lazar, Michal Brownstien, Alexander Botvinnik, Chloe Shevakh, Orr Shahar, Tzuri Lifschytz, Bernard Lerer

Abstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michal LazarBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Michal BrownstienBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Alexander BotvinnikBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Chloe ShevakhBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Orr ShaharBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Tzuri LifschytzBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.
Bernard LererBiological Psychiatry Laboratory and Hadassah BrainLabs, Center for Psychedelic Research, Hebrew University, Jerusalem, Israel.ORCID 0000-0002-9914-632X

Funding

Back of the Yards Algae SciencesNegev LabsParow Entheobiosciences
6 · The paper itself

Abstract

backgroundSAPAP3-knockout (SAPAP3-KO) mice develop excessive self-grooming behavior at 4-6 months of age, serving as a model for obsessive-compulsive disorder (OCD). Given that anxiety often precedes OCD diagnosis in humans, this study investigated whether juvenile SAPAP3-KO mice exhibit anxiety-like behaviors before developing the self-grooming phenotype, and whether such behaviors respond to psilocybin (PSIL) treatment. The study also examined 4 key neuroplasticity-related synaptic proteins-GAP43, PSD95, synaptophysin, and SV2A-as SAPAP3 is a postsynaptic scaffold protein that interacts with PSD95 and may affect synaptic function.

methodsTwo studies were conducted using male and female juvenile (10-13 weeks) SAPAP3-KO mice. Study 1 compared behavioral phenotypes between homozygous (HOM), heterozygous, and wild-type (WT) mice. Study 2 evaluated a different sample of HOM and WT mice and assessed the effect of PSIL (4.4 mg/kg) on identified behavioral differences. Both studies included comprehensive behavioral testing focused on anxiety-like behavior, social interaction, and cognitive function. Additionally, levels of 4 synaptic proteins were measured by western blots in the frontal cortex, hippocampus, amygdala, and striatum of juvenile and adult SAPAP3-KO mice.

resultsIn both studies, juvenile HOM SAPAP3-KO mice showed significant anxiety-like behaviors compared to WT mice, spending less time in open field center, and elevated plus maze open arms. They also buried fewer marbles and found fewer buried Oreos than WT mice. Psilocybin treatment did not improve these behavioral manifestations. Analysis of synaptic proteins revealed significant increases in GAP43, synaptophysin, and SV2A across multiple brain regions in adult male HOM mice and of SV2A in the frontal cortex of HOM females compared to WT, but not in juvenile mice of either sex.

conclusionsJuvenile SAPAP3-KO mice exhibit anxiety-like behaviors before developing the characteristic excessive self-grooming phenotype, paralleling the prodromal anxiety often seen in human OCD. Unlike in adult SAPAP3-KO mice, these manifestations were not responsive to PSIL treatment. The age-dependent increases in synaptic proteins observed in adult (but not juvenile) male SAPAP3-KO mice HOM for the deletion and to a lesser extent in female homozygotes, may represent compensatory plasticity changes in response to the phenotype. These results provide insights into the developmental trajectory of OCD-like behaviors and associated neuroplastic adaptations.

Indexed as

AnxietyBehavior, AnimalHallucinogensNerve Tissue ProteinsNeuronal PlasticityObsessive-Compulsive DisorderAnimalsDisease Models, AnimalDisks Large Homolog 4 ProteinFemaleGAP-43 ProteinGroomingMaleMiceMice, KnockoutSynaptophysinDisks Large Homolog 4 ProteinDlg4 protein, mouseGAP-43 ProteinHallucinogensNerve Tissue ProteinsSapap3 protein, mouseSynaptophysinSyp protein, mousehead-body twitchesobsessive-compulsive disorderSAPAP3self-groomingTourette’s syndrome

Identifiers

PMID40156912
PMCPMC12062877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.